1 study found for:    20222106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Alendronate;   Drug: Denosumab;   Drug: Placebo

Indicates status has not been verified in more than two years